| The 2.0 AX‐ray crystal structure of chicken egg white cystatin and its possible mode of interaction with cysteine proteinases. W Bode, R Engh, D Musil, U Thiele, R Huber, A Karshikov, J Brzin, J Kos, ... The EMBO journal 7 (8), 2593-2599, 1988 | 792 | 1988 |
| Targeting cancer cells using PLGA nanoparticles surface modified with monoclonal antibody P Kocbek, N Obermajer, M Cegnar, J Kos, J Kristl Journal of controlled release 120 (1-2), 18-26, 2007 | 587 | 2007 |
| Cysteine proteinases and their endogenous inhibitors: target proteins for prognosis, diagnosis and therapy in cancer J Kos, TT Lah Oncology reports 5 (6), 1349-1410, 1998 | 384 | 1998 |
| Discovery, biological evaluation, and crystal structure of a novel nanomolar selective butyrylcholinesterase inhibitor B Brus, U Kosak, S Turk, A Pislar, N Coquelle, J Kos, J Stojan, JP Colletier, ... Journal of medicinal chemistry 57 (19), 8167-8179, 2014 | 306 | 2014 |
| Cysteine proteinase inhibitors stefin A, stefin B, and cystatin C in sera from patients with colorectal cancer: relation to prognosis J Kos, M Krasovec, N Cimerman, HJ Nielsen, IJ Christensen, N Brünner Clinical Cancer Research 6 (2), 505-511, 2000 | 291 | 2000 |
| Lysosomal cathepsins: structure, role in antigen processing and presentation, and cancer V Turk, B Turk, G Gunčar, D Turk, J Kos Advances in enzyme regulation 42, 285-303, 2002 | 276 | 2002 |
| Proteins of higher fungi–from forest to application J Erjavec, J Kos, M Ravnikar, T Dreo, J Sabotič Trends in biotechnology 30 (5), 259-273, 2012 | 270 | 2012 |
| Serum cystatin C, a potent inhibitor of cysteine proteinases, is elevated in asthmatic patients N Cimerman, PM Brguljan, M Krašovec, S Šuškovič, J Kos Clinica chimica acta 300 (1-2), 83-95, 2000 | 270 | 2000 |
| Cathepsins B, H, and L and their inhibitors stefin A and cystatin C in sera of melanoma patients. J Kos, B Stabuc, A Schweiger, M Krasovec, N Cimerman, N Kopitar-Jerala, ... Clinical cancer research: an official journal of the American Association …, 1997 | 262 | 1997 |
| Cystatins in immune system Š Magister, J Kos Journal of Cancer 4 (1), 45, 2012 | 260 | 2012 |
| Cysteine proteinases and their inhibitors in extracellular fluids: markers for diagnosis and prognosis in cancer J Kos, B Werle, T Lah, N Brunner The International journal of biological markers 15 (1), 84-89, 2000 | 257 | 2000 |
| Mechanism of inhibition of papain by chicken egg white cystatin: Inhibition constants of N-terminally truncated forms and cyanogen bromide fragments of the inhibitor W Machleidt, U Thiele, B Laber, I Assfalg-Machleidt, A Esterl, G Wiegand, ... FEBS letters 243 (2), 234-238, 1989 | 237 | 1989 |
| Microbial and fungal protease inhibitors—current and potential applications J Sabotič, J Kos Applied microbiology and biotechnology 93 (4), 1351-1375, 2012 | 220 | 2012 |
| Serum cystatin C, a new marker of glomerular filtration rate, is increased during malignant progression J Kos, B S̆tabuc, N Cimerman, N Brunner Clinical chemistry 44 (12), 2556-2557, 1998 | 217 | 1998 |
| Cysteine cathepsins (proteases)—on the main stage of cancer? V Turk, J Kos, B Turk Cancer cell 5 (5), 409-410, 2004 | 207 | 2004 |
| Prognostic significance of cathepsins B and L in primary human breast cancer. JA Foekens, J Kos, HA Peters, M Krasovec, MP Look, N Cimerman, ... Journal of clinical oncology 16 (3), 1013-1021, 1998 | 185 | 1998 |
| The magic of crystal structure-based inhibitor optimization: development of a butyrylcholinesterase inhibitor with picomolar affinity and in vivo activity U Kosak, B Brus, D Knez, S Zakelj, J Trontelj, A Pislar, R Sink, M Jukic, ... Journal of medicinal chemistry 61 (1), 119-139, 2018 | 180 | 2018 |
| Development of an in-vivo active reversible butyrylcholinesterase inhibitor U Košak, B Brus, D Knez, R Šink, S Žakelj, J Trontelj, A Pišlar, J Šlenc, ... Scientific reports 6 (1), 39495, 2016 | 180 | 2016 |
| Intracellular and extracellular cathepsin B facilitate invasion of MCF-10A neoT cells through reconstituted extracellular matrix in vitro A Premzl, V Zavašnik-Bergant, V Turk, J Kos Experimental cell research 283 (2), 206-214, 2003 | 180 | 2003 |
| Regulation of the Activity of Lysosomal Cysteine Proteinases by pH-lnduced Inactivation and/or Endogenous Protein Inhibitors, Cystatins B Turk, JG Bieth, I Björk, I Dolenc, D Turk, N Cimerman, J Kos, A Čolič, ... Biological Chemistry 376 (4), 225-230, 1995 | 177 | 1995 |
